Recruitment unclearEUCTR 2014-002002-20

A multicentre randomized double-blind placebo controlled discontinuation trial of methylphenidate

This historical record does not confirm current site availability.

Historical research recordNetherlandsADHD

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Netherlands
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Recruitment unclear
Enrollment listed in the registry: Not clearly listed
Sponsor: UMCG
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 4
Locations: Netherlands
Age range: Not clearly listed
Official registry ID: EUCTR 2014-002002-20
Official title: Show the full official title
A multicentre randomized double-blind placebo controlled discontinuation trial of methylphenidate

Need help understanding this study?

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruitment & locations

Status unknown

Netherlands

Registry details

Historical country statuses

Netherlands — Ongoing

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is UMCG.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me